Mustang Bio, Inc. entered into a Securities Purchase Agreement with an investor for a registered direct offering of common stock and pre-funded warrants, as well as a concurrent private placement of unregistered warrants, resulting in approximately $4.4 million in gross proceeds. The company intends to use the net proceeds for general corporate purposes and working capital requirements.